Plunkett Research Online: Ikena Oncology Inc

IKENA ONCOLOGY INC (IKNA) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Ikena Oncology Inc is a targeted oncology company developing precision medicines tailored to biomarker-defined patient groups with specific unmet needs. Its lead targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD.....


IKENA ONCOLOGY INC

Ticker: IKNA
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 857 273-8343
Fax:
Address: 645 Summer Street
Boston, MA 2210 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Mark ManfrediCEO/Director/Founder/President
Jotin MarangoCFO/Chief Accounting Officer/COO/Other Corporate Officer
See More
Ikena Oncology Inc is a targeted oncology company developing precision medicines tailored to biomarker-defined patient groups with specific unmet needs. Its lead targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture